Generic Ondansetronum
Description: Ondansetronum (Ondansetron) is an antiemetic used to prevent nausea and vomiting. Your pharmacist may know of alternate uses for Ondansetronum (Ondansetron). Further Ondansetronum reference material...
Also known as: Ondansetrón, Ondansetrona, Zofran, Zofran ODT, Zofran Zydis, Zophren, Ondansetron (generic name).
What is Generic Ondansetronum?
Generic Ondansetronum, like all generics, is the name given to the
prescription Ondansetron medication manufactured by any company other than the
original inventor of Ondansetronum. The only true difference between brand name Ondansetronum
and generic Ondansetronum is that generic Ondansetronum is always less expensive.
Discount Generic Ondansetronum - No Prior Prescription Needed*
Generic Ondansetronum is at Easy MD | Medication | Strength | Quantity | Price | Easy MD | |
| Ondansteron Hydrochloride, Dihydrate | 4 mg | 30 tablets | $68.67 | Order | | Ondansteron Hydrochloride, Dihydrate | 4 mg | 60 tablets | $115.33 | Order | | Ondansteron Hydrochloride, Dihydrate | 4 mg | 90 tablets | $162.00 | Order | | Ondansteron Hydrochloride, Dihydrate | 8 mg | 30 tablets | $103.67 | Order | | Ondansteron Hydrochloride, Dihydrate | 8 mg | 60 tablets | $185.33 | Order | | Ondansteron Hydrochloride, Dihydrate | 8 mg | 90 tablets | $267.00 | Order |
All medications at Easy MD are generics.
How To Buy Generic Ondansetronum Online
Buy discount generic Ondansetronum (Ondansetron) online by clicking on one of the low
prices shown. You'll be sent to our secure shopping cart where you can safely
complete your transaction.
¿Cuál es Ondansetronum genérico?
El Ondansetronum genérico, como todo el generics, es el nombre dado a
la medicación de la prescripción Ondansetron fabricada por cualquier compañía con
excepción del inventor original de Ondansetronum. La única diferencia verdadera entre
la marca Ondansetronum y Ondansetronum genérico es que Ondansetronum genérico es siempre menos
costoso. Ninguna prescripción anterior necesitada.
Was ist generisches Ondansetronum?
Generisches Ondansetronum, wie alle generische medikation, ist die
medikation der verordnung Ondansetron, die von jeder möglicher firma anders als
den ursprünglichen erfinder von Ondansetronum hergestellt wird. Der einzige
zutreffende unterschied zwischen markennamen Ondansetronum und generisches Ondansetronum ist,
daß generisches Ondansetronum immer weniger kostspielig ist.
Che cosa è Ondansetronum generico?
Ondansetronum generico, come tutto il farmaco generico, è farmaco di
prescrizione Ondansetron prodotto da tutta l'azienda tranne l'inventore originale
di Ondansetronum. L'unica differenza allineare fra la marca Ondansetronum e Ondansetronum generico è
che Ondansetronum generico è sempre meno costoso.
Ondansetronum - Health Bulletin
Breast Cancer Finding It, Treating ItThe first story is from the European Breast Cancer Conference beingheld now. The European Breast Cancer Conference includes European andinternational researchers, medical and lay contributors, all devoted to multi disciplinarybreast cancer research, prevention, treatment and care or advocacy. One ofthe papers discussed the finding that more older women (ages 50-69) today havedense breast tissue similar to that normally associated with younger women. Densebreast tissue makes it more difficult to analyze and interpret mammograms. The researchers had no explanation for this finding.
Comment: Either a certain percentage of older women have always had densebreast tissue and it just wasn't appreciated on mammograms or there is someenvironmental explanation (hormones, diet, etc.). What is going on here?
The second story is from the US. A new study finds that treatment forlocalized breast cancer called ductal carcinoma in situ (DCIS) varies widely inthe US from "too aggressive" to "not aggressive enough." Treatment options include mastectomy, lumpectomy, lumpectomy with radiation anddissection of the axillary nodes. For example, almost half of US womenundergoing a lumpectomy for DCIS did not receive radiation therapy.
Comments: In an accompanying editorial, Monica Morrow, MD writes that the"wide variation in recurrence rates is the crux of the uncertainty in DCIS(treatment)....In the absence of data that allow us to identify which women withDCIS are at risk for invasive recurrence, how should therapy be selected?"
She argues for a better understanding of patient preferences and for ways tohelp women make the appropriate decisions. But she acknowledges that thereare wide variations in attitudes toward risk-taking among different US women She brings up the current numbers with breast implants: 1.64 per 1000women in the East versus 16.4 per 1000 women in Texas! She asks whetherthese numbers reflect undertreatment in the East and overtreatment in Texas --or simply a reflection of the diversity among American women. Aninteresting insight. Barbara K. Hecht,Ph.D.
Frederick Hecht, M.D.
Medical Editors, MedicineNet.com First Story Second Story Overall
Read entire article...
Please verify your local import regulations; the ability for a pharmacy to
offer a medication without a prescription does not negate any local requirement
you may have.
NOTICE: By using this site, you agree to verify and comply with your
country's rules and regulations should you undertake to purchase from any of
the listed pharmacies.
|
|
